'I re­al­ly don’t look back': Janet Wood­cock on her tran­si­tion away from drugs

Janet Wood­cock may have one of the most his­tor­i­cal­ly long and drug-in­tense tenures in FDA his­to­ry, but her new role is out­side of all things phar­ma and the once-act­ing FDA com­mis­sion­er isn’t look­ing back.

“No I re­al­ly don’t look back,” Wood­cock told End­points News via email on Mon­day morn­ing. “Yes I will be tran­si­tion­ing. Longer dis­cus­sion on in­fra­struc­ture need­ed.”

FDA Com­mis­sion­er Rob Califf an­nounced in a memo to staff last week that Wood­cock would be tran­si­tion­ing away from her work on phar­ma­ceu­ti­cals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER